What's happening
Live detector signal
Generated 00:43 ET
IRLA — IRulya Therapeutics Inc. Common Stock is up 13.4%, at 38.30, on $4.5M traded, 1.3× 20-day volume, 0.13× float rotation. Score 86. Primary driver: 13.0% float rotation. Supply intelligence: squeeze-prone · 82.
Get alerts on $IRLA
Halts, resumptions, new filings, and updated reports — in your inbox within minutes of the event.
Free · one email per event, no digests or spam · unsubscribe anytime · joins real followers
Free float
899.2K
2026-10-14
Shares out
10.8M
latest detail
Market cap
$418.7M
at ref price
Short interest
14.2%
2026-10-30
Float rotation
0.13×
latest snapshot
20d dollar vol
$3.2M
baseline
Gap quality
squeeze-prone · 82
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
very tight float
detector reason
Supply factor
elevated short interest
detector reason
This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.
2026-11-10 13:55 ETSignalIRulya Therapeutics Inc. Common Stock is up 13.4%, at 38.30, on $4.5M traded, 1.3× 20-day volume, 0.13× float rotation. Score 86. Primary driver: 13.0% float rotation. Supply intelligence: squeeze-prone · 82.
2026-10-198-KItem 7.01 — Regulation FD disclosure; Item 9.01 — Financial statements and exhibits SEC
2026-10-098-KItem 5.02 — Director or officer departure/election/appointment; Item 5.03 — Amendments to charter or bylaws +1 more SEC
2026-10-068-KItem 5.02 — Director or officer departure/election/appointment; Item 5.03 — Amendments to charter or bylaws +1 more SEC
2026-09-148-KItem 2.01 — Completion of acquisition or disposition of assets; Item 9.01 — Financial statements and exhibits +1 more SEC
Latest detector signalscore 86